瘤病毒:临床试验和环境风险评估元素的泄漏数据的库存
Sheela Onnockx1, Aline Baldo1, Katia Pauwels1
1Sciensano, Service Biosafety and Biotechnology, Rue Juliette Wytsmanstraat 14, B-1050 Brussels, Belgium.
Vaccines
|September 28, 2023
概括
瘤病毒 (OV) 对癌症治疗有前途,但需要对环境风险进行评估. 本综述分析了OV泄漏数据,这对于评估传播风险和为未来的研究设计提供信息至关重要.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 监管科学 监管科学
- 环境风险评估环境风险评估
背景情况:
- 减弱和/或转基因瘤病毒 (OV) 正在成为一种重要的癌症治疗方式.
- 使用转基因病毒需要遵守欧盟的监管框架,包括环境风险评估 (ERA).
- 评估非试验个体和环境对OV的潜在暴露是ERA的一个关键组成部分.
研究的目的:
- 提供从临床应用中获得的瘤性病毒泄漏数据的最全面和最新的综述.
- 突出抛光数据在评估OV的传输潜力的重要性,特别是具有复制能力的OV.
- 为设计可靠的脱落研究提供指导,参考现有的欧洲和国际指南.
主要方法:
- 对型病毒发表的临床分泌数据进行系统审查和综合.
- 在环境风险评估要求的背景下,分析掉落数据.
- 条件复制的OV和复制缺陷的病毒载体之间的脱落特征的比较.
主要成果:
- 该审查整合了现有的型病毒泄漏数据,确定了收集方法中的差距和不一致性.
- 泄漏数据被证实是确定瘤病毒在环境中传播风险的关键因素.
- 需要标准化和改进的方法来收集流失数据是显而易见的.
结论:
- 本次审查强调了脱落数据在监管批准和瘤病毒安全临床使用中的关键作用.
- 这些发现强调了需要加强射研究设计,以准确评估环境暴露和传播风险的必要性.
- 这篇文章作为一种资源,有助于开发未来的型病毒散射研究,与监管预期保持一致.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
145
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
145
01:25Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K